CCCompany

Study shows severe stress urinary improved by Yentreve

Published in Mental Health Law Weekly, October 30th, 2004

Data published in Obstetrics and Gynecology show that for women with severe stress urinary incontinence (SUI), Yentreve (duloxetine hydrochloride) works quickly to reduce the frequency of their incontinence episodes and improves their quality of life.

All women enrolled in the study were awaiting continence surgery however, after 8 weeks on Yentreve, 20% of these patients reconsidered their willingness to undergo surgery.

"This study has important implications for clinical practice as it shows that Yentreve may provide an alternative to surgery for some women with stress urinary incontinence. We know that surgery is an effective option but it...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Mental Health Law Weekly

Source: Mental Health Law Weekly (2004-10-30)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry